GLP-1 / GIP / Glucagon Triple Agonist
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, studied for its potent effects on body weight reduction and metabolic health in research models.
Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Gly-Lys-Gly-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2